Holding(s) in Company (2941H)
May 25 2011 - 11:01AM
UK Regulatory
TIDMHIK
RNS Number : 2941H
Hikma Pharmaceuticals Plc
25 May 2011
Notification of Major Interests in Shares
LONDON, 25 May 2011 - Hikma Pharmaceuticals PLC ("Hikma") (LSE:
HIK) (DIFX: HIK), the fast growing multinational pharmaceuticals
group, announces as follows:
1 Identity of the issuer or the underlying Hikma Pharmaceuticals PLC
issuer of existing shares to which the
voting rights are attached
----------------------------------------- --------------------------
2 Reason for the notification
------------------------------------------------- ----
An acquisition or disposal of voting Yes
rights
------------------------------------------------- ----
An acquisition or disposal of financial No
instruments which may result in the acquisition
of shares already issues to which voting
rights are attached
------------------------------------------------- ----
An event changing the breakdown of voting No
rights
------------------------------------------------- ----
Other (please specify): Compliance with No
the Transparency Directive
------------------------------------------------- ----
Full name of the person subject to the
3 notification obligation Norges Bank
---------------------------------------- ------------
4 Full name of shareholders N/A
---------------------------------------- ------------
Date of the Transaction (and date on
which the threshold crossed is reached
5 differently) 24 May 2011
---------------------------------------- ------------
6 Date on which the issuer notified 25 May 2011
---------------------------------------- ------------
7 Threshold that is crossed 3%
---------------------------------------- ------------
8 Notified details (ABC)
-----------------------
A. Voting rights attached to shares
---------------------------------------------------------------------------------------------------------
Class type
of shares
(if possible Situation previous
using the to the triggering Resulting situation after the triggering
ISIN code) transaction transaction
-------------- ----------------------- ----------------------------------------------------------------
Number
Number of of voting Number of voting % of voting
shares rights Number of shares rights rights
-------------- ---------- ----------- --------------------- --------------------- ------------------
Direct Indirect Direct Indirect Direct Indirect
-------------- ---------- ----------- ---------- --------- ---------- --------- ------- ---------
Ordinary
Shares (0.10
GBP)
GB00B0LCW083 5,791,830 5,791,830 5,876,885 0 5,876,885 0 3.02% 0%
-------------- ---------- ----------- ---------- --------- ---------- --------- ------- ---------
B. Qualifying Financial instruments
----------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------
Type of Expiration Exercise/Conversion Number of voting % of voting
financial Date Period/Date rights that may be rights
instrument acquired if the
instrument if
exercised/converted
----------- ----------- -------------------- -------------------- ------------
- - - - -
----------- ----------- -------------------- -------------------- ------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments
------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/Conversion Number of % of voting
financial Price Date Period/Date voting rights
instrument rights
instrument
refers to
----------- --------- ----------- -------------------- ----------- ------------------
Nominal Delta
----------- --------- ----------- -------------------- ----------- -------- --------
- - - - - - -
----------- --------- ----------- -------------------- ----------- -------- --------
Total A+B+C
---------------------------------------------
Number of Voting rights % of voting rights
------------------------ -------------------
5,876,885 3.02%
------------------------ -------------------
9 Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable
----------------------------------------------------------------------
N/A
----------------------------------------------------------------------
Proxy Voting
---------------------------------------------------------
10 Name of the proxy holder Norges Bank
--- -------------------------------------- ------------
11 Number of voting rights proxy holder N/A
will cease to hold
--- -------------------------------------- ------------
12 Date on which proxy holder will cease N/A
to hold voting rights
--- -------------------------------------- ------------
Notification using the
total voting rights figure
13 Additional Information of 194,553,607
--- -------------------------- ----------------------------
14 Contact name: Jonas Lexmark, Norges Bank
--- -------------------------- ----------------------------
15 Contact telephone number: +47 24 07 31 34
--- -------------------------- ----------------------------
- ENDS -
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed pharmaceutical
products. Hikma's operations are conducted through three
businesses: "Branded", "Injectables" and "Generics". Hikma's
operations are based principally in the Middle East and North
Africa ("MENA") region, where it is a market leader and sells
across 17 countries, the United States and Europe. In 2010, the
Group achieved revenues of $731 million (2009 $637 million) and
profit attributable to shareholders of $99 million (2009 $78
million).
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVVSRAKAVUAR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
